| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 7 | +1,423,704 | 100% | $3.13 | +$4,460,990 |
| Sells | 0 | ||||
| Net | +7 | +1,423,704 | 100% | +$4,460,990 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Genexine Inc. | 10%+ Owner | $173,462,643 | 26 Apr 2019 | ||
| Young-Jin Kim | Director | $78,981,947 | +$3,999,999 | +5.3% | 19 Nov 2025 |
| HANDOK, INC. | Director, 10%+ Owner | $10,051,937 | 15 Oct 2021 | ||
| Daron Evans | Cfo | $1,552,984 | +$210,694 | +16% | 15 Dec 2025 |
| Nevan C. Elam | CEO, Director | $1,019,379 | +$85,879 | +9.2% | 15 Dec 2025 |
| Gil M. Labrucherie | Director | $1,002,371 | 19 Nov 2025 | ||
| Brian Kenneth Roberts | Chief Medical Officer | $672,378 | +$58,539 | +9.5% | 16 Dec 2025 |
| Nerissa Kreher | Director | $538,313 | +$9,997 | +1.9% | 19 Nov 2025 |
| Philippe Fauchet | Director | $510,045 | 19 Nov 2025 | ||
| Sunil Patilal Karnawat | Chief Commercial Officer | $209,091 | +$19,599 | +10% | 15 Dec 2025 |
| Wladimir Hogenhuis | Director | $202,250 | +$76,282 | +61% | 16 Dec 2025 |
| Erik Harris | Director | $192,990 | 19 Nov 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|